UroGen Pharma Ltd. Stock Chart

UroGen Pharma Ltd. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About UroGen Pharma Ltd.

LSE
Market Cap
$805.00M
Shares Out.
46.26M
Sector
Health Technology
Industry
Biotechnology

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

www.urogen.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free